業績　聖マリアンナ医科大学脳神経内科学

Imai T, Shibata S, Shinohara K, Sakurai K, Horiuchi M, Sakai K, Asai S, Hasegawa Y.
IgG4-related hypophysitis diagnosed by retroperitoneal mass biopsy in a patient presenting with abducens nerve palsy.
Medicine (Baltimore) , 2020 Oct 99(40):e22484. doi: 10.1097/MD.0000000000022484.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535663/pdf/medi-99-e22484.pdf

Shimizu J, Yamano Y, Kawahata K, Suzuki N.
Elucidation of predictors of disease progression in patients with relapsing polychondritis at the onset: potential impact on patient monitoring.
BMC Rheumatol. 2020 Sep 11;4:41. doi: 10.1186/s41927-020-00141-8.

https://bmcrheumatol.biomedcentral.com/articles/10.1186/s41927-020-00141-8

Takao N, Hagiwara Y, Shimizu T, Soga K, Tsuchihashi Y, Otsubo H, Tatsuno K, Takaishi S, Usuki N, Yoshie T, Takada T, Ueda T, Hasegawa Y, Yamano Y.
Preprocedural Carotid Plaque Echolucency as a Predictor of In-stent Intimal Restenosis after Carotid Artery Stenting.
J Stroke Cerebrovasc Dis,
2020 Dec;29(12):105339.　doi: 10.1016/j.jstrokecerebrovasdis.2020.105339.

https://www.sciencedirect.com/science/article/pii/S1052305720307576

Tsuchihashi Y, Shimizu T, Akiyama H, Hagiwara Y, Soga K, Takao N, Uchino K, Yanagisawa T, Yamauchi J, Sato T, Hasegawa Y, Yamano Y.
The Risk Factors for Death within 6 Months After Ischemic Stroke in Patients with Cancer.
J Stroke Cerebrovasc Dis,
2020 Dec;29(12):105365.　doi: 10.1016/j.jstrokecerebrovasdis.2020.105365.

https://www.sciencedirect.com/science/article/pii/S1052305720307837

Okuma K, Kuramitsu M, Niwa T, Taniguchi T, Masaki Y, Ueda G, Matsumoto C, Sobata R, Sagara Y, Nakamura H, Satake M, Miura K, Fuchi N, Masuzaki H, Okayama A, Umeki K, Yamano Y, Sato T, Iwanaga M, Uchimaru K, Nakashima M, Utsunomiya A, Kubota R, Ishitsuka K, Hasegawa H, Sasaki D, Koh KR, Taki M, Nosaka K, Ogata M, Naruse I, Kaneko N, Okajima S, Tezuka K, Ikebe E, Matsuoka S, Itabashi K, Saito S, Watanabe T, Hamaguchi I.
Establishment of a novel diagnostic test algorithm for human T-cell leukemia virus type 1 infection with line immunoassay replacement of western blotting: a collaborative study for performance evaluation of diagnostic assays in Japan.
Retrovirology, 2020 Aug 17(1):26. doi: 10.1186/s12977-020-00534-0.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444053/pdf/12977_2020_Article_534.pdf

Tokuyama Y, Takada T, Usuki N, Takaishi S, Tatsuno K, Hamada Y, Otubo H, Ueda T
Effects of Aspiration and Re-transfusion Technique with Carotid Artery Stenting.
J. Neuroendovascular Ther.
2020 Nov;14(11):475-480. doi: 10.5797/jnet.oa.2019-0109.

https://www.jstage.jst.go.jp/article/jnet/advpub/0/advpub_oa.2019-0109/_pdf/-char/en

Yamakawa N, Yagishita N, Matsuo T, Yamauchi J, Ueno T, Inoue E, Takata A, Nagasaka M, Araya N, Hasegawa D, Coler-Reilly A, Tsutsumi S, Sato T, Araujo A, Casseb J, Gotuzzo E, Jacobson S, Martin F, Puccioni-Sohler M, Taylor GP, Yamano Y; Japan Clinical Research Group on HAM/TSP.
Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis.
Orphanet J Rare Dis. 2020 Jul 3;15(1):175. doi: 10.1186/s13023-020-01451-3.
PMID: 32620176

Yamasaki Y, Ooka S, Tsuchida T, Nakamura Y, Hagiwara Y, Naitou Y, Ishibashi Y, Ikeda H, Sakurada T, Handa H, Nishine H, Takita M, Morikawa D, Yoshida H, Fujii S, Morisawa K, Takemura H, Fujitani S, Kunishima H.
The peripheral lymphocyte count as a predictor of severe COVID-19 and the effect of treatment with ciclesonide.
Virus Res,
2020 Dec;290:198089. doi: 10.1016/j.virusres.2020.198089.

https://www.sciencedirect.com/science/article/pii/S016817022030753X?via%3Dihub

Sakurai K, Shinohara K, Imai T, Yamano Y, Hasegawa Y.
A Case of Severe Multiple Sclerosis Manifesting upon GnRH Agonist Therapy for Uterine Fibroids: A Case Report.
Intern Med,
2020 Dec 1;59(23):3093-3096.

https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_4839-20/_pdf/-char/en

Yoshie T, Yu Y, Jiang H, Honda T, Trieu H, Scalzo F, Saver JL, Liebeskind DS, on behalf of the UCLA Reperfusion Therapy Investigators.
Perfusion Parameter Thresholds that Discriminate Ischemic Core Vary with Time from Onset in Acute Ischemic Stroke
AJNR Am J Neuroradiol,
2020 Oct;41(10):1809-1815. doi: 10.3174/ajnr.A6744.

http://www.ajnr.org/content/early/2020/08/27/ajnr.A6744

Koga M, Yamamoto H, Inoue M, Asakura K, Aoki J, Hamasaki T, Kanzawa T, Kondo R, Ohtaki M, Itabashi R, Kamiyama K, Iwama T, Nakase T, Yakushiji Y, Igarashi S, Nagakane Y, Takizawa S, Okada Y, Doijiri R, Tsujino A, Ito Y, Ohnishi H, Inoue T, Takagi Y, Hasegawa Y, Shiokawa Y, Sakai N, Osaki M, Uesaka Y, Yoshimura S, Urabe T, Ueda T, Ihara M, Kitazono T, Sasaki M, Oita A, Yoshimura S, Fukuda-Doi M, Miwa K, Kimura K, Minematsu K, Toyoda K; THAWS Trial Investigators.
Thrombolysis With Alteplase at 0.6 mg/kg for Stroke With Unknown Time of Onset: A Randomized Controlled Trial.
Stroke, 51(5):1530-1538, 2020.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185058/

Nagasaka M, Yamagishi M, Yagishita N, Araya N, Kobayashi S, Makiyama J, Kubokawa M, Yamauchi J, Hasegawa D, Coler-Reilly ALG, Tsutsumi S, Uemura Y, Arai A, Takata A, Inoue E, Hasegawa Y, Watanabe T, Suzuki Y, Uchimaru K, Sato T, Yamano Y.
Mortality and risk of progression to adult T-cell leukemia/lymphoma in HTLV-1-associated myelopathy/tropical spastic paraparesis.
Proc Natl Acad Sci USA, 117(21):11685-11691, 2020

https://www.pnas.org/content/117/21/11685.long

Hara D, Akamatsu M, Mizukami H, Kato B, Suzuki T, Oshima J, Akasu Y, Hasegawa Y.
Opalski Syndrome Treated with Intravenous Recombinant Tissue Type Plasminogen Activator—Case Report and Review of Literature.
J Stroke Cerebrovasc Dis, 2020 Aug;29(8):104806. doi:
10.1016/j.jstrokecerebrovasdis.2020.104806, 2020.

https://www.sciencedirect.com/science/article/abs/pii/S1052305720301907?via%3Dihub

Yamauchi J, Sato T, Yagishita N, Araya N, Hasegawa D, Tsutsumi S, Nagasaka M, Coler-Reilly A, Inoue E, Takata A, Hasegawa Y, Yamano Y.
Use of cerebrospinal fluid CXCL10 and neopterin as biomarkers in HTLV-1-associated myelopathy/tropical spastic paraparesis treated with steroids.
J Neurol Neurosurg Psychiatry, 91(3):321-323, 2020.

https://jnnp.bmj.com/content/91/3/321.long

Takeda R, Ishigaki T, Ohno N, Yokoyama K, Kawamata T, Fukuyama T,
Araya N, Yamano Y, Uchimaru K, Tojo A.
Immunophenotypic analysis of cerebrospinal fluid reveals concurrent development of ATL in the CNS of a HAM/TSP patient.
Int J Hematol. 111(6):891-896, 2020.

https://link.springer.com/article/10.1007/s12185-019-02815-7

Hara D, Akamatsu M, Mizukami H, Kato B, Suzuki T, Oshima J, Hasegawa Y.
A Case of Subacute Combined Degeneration of Spinal Cord Diagnosed by Vitamin B12 Administration Lowering Methylmalonic Acid.
Case Rep Neurol, 12(1):27-34, 2020

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011716/

Kikuno M, Ueno Y, Shimizu T, Kuriki A, Tateishi Y, Doijiri R, Shimada Y, Takekawa H, Yamaguchi E, Koga M, Kamiya Y, Ihara M, Tsujino A, Hirata K, Toyoda K, Hasegawa Y, Aizawa H, Hattori N, Urabe T; CHALLENGE ESUS/C.S. collaborators.
Underlying embolic and pathologic differentiation by cerebral microbleeds in cryptogenic stroke.
J Neurol, 267(5):1482-1490, 2020.

https://link.springer.com/article/10.1007/s00415-020-09732-4

Shimizu T, Kashima S, Akiyama H, Isahaya K, Hasegawa Y.
The ASCOD Phenotyping of Embolic Strokes of Undetermined Source.
J Stroke Cerebrovasc Dis, 29(2):104491, 2020.

https://www.sciencedirect.com/science/article/pii/S1052305719305750?via%3Dihub